Regeneration of the binding properties of adenovirus 12 early region 1a proteins after preparation under denaturing conditions

Virology

Volumn 244, Issue 1, 1998, Pages 230-242

  Grand, Roger J A ^a   Gash, Lisa ^a   Milner, Anne E ^a   Molloy, David P ^a   Szestak, Tadge ^a   Turnell, Andrew S ^a   Gallimore, Phillip H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; TATA BINDING PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; DENATURATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STRUCTURE ANALYSIS;

ADENOVIRIDAE; DNA VIRUSES; ESCHERICHIA COLI; HUMAN ADENOVIRUS TYPE 12;

EID: 0032565315     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9081     Document Type: Article

References (42)

1. Bayley S. T., Mymryk J. S. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5:1994;425-444.
2. Bernards R., van der Eb A. J. Adenovirus transformation and oncogenicity. Biochim. Biophys. Acta. 783:1984;187-204.
3. Boulanger P. A., Blair G. E. Expression and interaction of human adenovirus oncoproteins. Biochem. J. 281:1991;281-299.
4. Boyd J. M., Subramanian T., Schaefer U., La Regina M., Bayley S., Chinnadurai G. A region in the C terminus of adenovirus 2/5 E1A proteins is required for association with a cellular phosphoprotein and is important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:1993;469-478.
5. Braithwaite A. W., Cheetham B. F., Li P., Parish C. R., Waldron-Stevens L. K., Bellet A. J. D. Adenovirus-induced alterations of the cell growth cycle: A requirement for expression of E1A but not E1B. J. Virol. 45:1985;192-199.
6. Bruner M., Dalie B., Spangler R., Harter M. L. Purification and biological characterisation of an adenovirus type 2 E1A protein expressed in Escherichia coli. J. Biol. Chem. 263:1988;3984-3989.
7. Chakrabartty A., Schellman J. A., Baldwin R. L. Large differences in the helix propensitites of alanine and glycine. Nature. 351:1991;586-588.
8. Chatton B., Bocco J. L., Gaire M., Hauss C., Reimund B., Goetz J., Kedinger C. Transcriptional activation by the adenovirus larger E1A product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1A. Mol. Cell. Biol. 13:1993;561-570.
9. Culp J. S., Webster L. C., Friedman D. J., Smith C. L., Huang W-J., Wu F. Y-H., Rosenberg M., Riciardi R. P. The 289 amino acid E1A protein of adenovirus binds zinc in a region that is important for transactivation. Proc. Natl. Acad. Sci. USA. 85:1988;6450-6454.
10. Ferguson B., Jones N., Richter J., Rosenberg M. Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional. Science. 224:1984;1343-1346.
11. Flint K. J., Jones N. C. Differential regulation of three members of the ATC/CREB family of DNA binding proteins. Oncogene. 6:1991;2019-2226.
12. Fraser R. A., Rossignol M., Heard D. J., Egly J. M., Chambon P. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome complex, is a DNA helicase. J. Biol. Chem. 272:1997;7122-7126.
13. Gallimore P. H., Byrd P. J., Whittaker J. L., Grand R. J. A. The properties of rat cells transformed by DNA plasmids containing adenovirus E1 DNA or specific fragments of the E1 region: A comparison of transforming efficiencies. Cancer Res. 45:1985;2670-2680.
14. Geisberg J. V., Lee W. S., Berk A. J., Ricciardi R. P. The zinc finger region of the adenovirus E1A transactivating domain complex with the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 91:1994;2488-2492.
15. Grand R. J. A., Perry S. V., Weeks R. A. Troponin C-like proteins (calmodulins) from mammalian smooth muscle and other tissues. Biochem. J. 177:1979;521-529.
16. Horikoshi N., Maguire K. J., Kralli A., Maldonado E., Reinberg D., Weinmann R. Direct interaction between adenovirus E1A and the TATA box binding transcription factor IID. Proc. Natl. Acad. Sci. USA. 88:1991;5124-5128.
17. Jones N. Transcriptional modulation by the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199:1995;59-80.
18. Krippl B., Ferguson B., Rosenberg M., Westphal H. Functions of purified E1A protein microinjected into mammalian cells. Proc. Natl. Acad. Sci. USA. 81:1984;6988-6992.
19. Lee J. W., Ryan F., Swaffield J. C., Johnstone S. A., Moore D. D. Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
20. Lee W. S., Kao C. C., Bryant G. O., Liu X., Berk A. J. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell. 67:1991;365-376.
21. Liu F., Green M. R. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1A protein. Cell. 61:1990;1217-1224.
22. Lyons R. H., Ferguson B. Q., Rosenberg M. Pentapeptide nuclear localisation signal in adenovirus E1A. Mol. Cell. Biol. 7:1987;2451-2456.
23. Kip1by the E1A oncoprotein in TGFβ-treated cells. Nature. 380:1996a;262-265.
24. Mal A., Piotrkowski A., Harter M. L. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes. J. Virol. 70:1996b;2911-2921.
25. Marqusee S., Robbins V. H., Baldwin R. L. Unusually stable helix formation in short alanine-based peptides. Proc. Natl. Acad. Sci. USA. 86:1989;5286-5290.
26. Maruyama K., Schiavi S. C., Huse W., Johnson G. L., Ruley H. E. Myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Oncogene. 1:1987;361-367.
27. Moran E. Mammalian cell growth controls reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol. 5:1994;327-340.
28. Moran E., Mathews M. B. Multiple functional domains in the adenovirus E1A gene. Cell. 48:1987;177-178.
29. Patel G., Jones N. C. Activationin vitroof RNA polymerase II and III directed transformation by baculovirus produced E1A protein. Nucleic Acids Res. 18:1990;2909-2915.
30. Peeper D. S., Zantema A., Dowdy S. F., van der Eb A. J. Expression, purification and functional characterisation of adenovirus 5 and 12 E1A proteins produced in insect cells. Virology. 190:1992;733-745.
31. Perrie W. T., Perry S. V. An electrophoretic study of low molecular weight components of myosin. Biochem. J. 119:1970;31-38.
32. Quinlan M. P., Grodzicker T. Adenovirus E1A 12S protein induces DNA synthesis and proliferation in primary epithelial cells in both the presence and absence of serum. J. Virol. 61:1987;673-682.
33. Rao L., Debbas M., Sabbatini P., Hockenberry D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:1992;7742-7746.
34. Rubin D. M., Coux O., Wefes I., Hengartner C., Young R. A., Goldberg A. L., Finley D. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature. 379:1996;655-657.
35. Swaffield J. C., Melcher K., Johnston S. A. A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein. Nature. 374:1995;88-91.
36. Wang H-G. H., Rikitake Y., Carter M. C., Yaciuk P., Abraham S. E., Zerler B., Moran E. Identification of specific adenovirus E1A N terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:1993;476-488.
37. Wang W., Chevray P. M., Nathans D. Mammalian Sug1 and c-Fos in the nuclear 26S proteasome. Proc. Natl. Acad. Sci. USA. 93:1996;8236-8240.
38. Webster K. A., Muscat G. E. O., Kedes L. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature. 332:1988;553-557.
39. Webster L. C., Ricciardi R. P. Trans dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor. Mol. Cell. Biol. 11:1991;4287-4296.
40. Whyte P., Williamson N. M., Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell. 58:1989;67-75.
41. Williams J., Williams M., Liu C., Telling G. Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr. Top. Microbiol. Immunol. 199:1995;149-175.
42. Yaciuk P., Moran E. Analysis with specific polyclonal antiserum indicates that the E1A-associated 300 kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase modification. Mol. Cell. Biol. 11:1991;5389-5397.